Talent

Jonathan Lim, M.D.

Jonathan Lim, M.D.

City Hill Founder

Dr. Jonathan Lim is a physician-turned-venturepreneur at City Hill and ARCH Venture who founds, funds and leads mission-driven for-profit and non-profit ventures dedicated to revitalizing people, planet and perspective. Within the City Hill Ventures and ARCH portfolios, Dr. Lim serves as Chairman, CEO and Co-Founder of Erasca; Chairman and Co-Founder of Boundless Bio; and Board Director of Maze Therapeutics. From 2003 to 2018, Dr. Lim was a leader and founding investor of four biotech companies (Halozyme, Eclipse, Ignyta and Bonti) that have collectively delivered seven approved therapeutic products for adult and pediatric indications in oncology, immunology and drug delivery, benefitting thousands of patients globally.

Dr. Lim is a philanthropist and advisor to non-profit organizations through City Hill Foundation and a film producer at City Hill Arts, dedicated to inspiring family entertainment with impact. Earlier in his career, Dr. Lim was a management consultant at McKinsey & Company, an NIH Postdoctoral Fellow at Harvard Medical School and Dana Farber Cancer Institute, and a general surgery resident at New York Hospital-Cornell and Memorial Sloan Kettering Cancer Center. He holds B.S. and M.S. degrees from Stanford University, an M.D. from McGill University, and an M.P.H. from Harvard University.

Karen Gilmore, CPA

Controller and Administrative Director

Karen Gilmore joined City Hill Ventures in early 2011 as Controller and currently serves as Vice President of Finance at Erasca. She has supported multiple portfolio companies of City Hill, including Erasca, Ignyta, Eclipse Therapeutics, and Medenovo. Ms. Gilmore has more than 25 years of experience serving both public and private companies in multiple industries, with a heavy concentration in biotech and medical device. Ms. Gilmore has provided Chief Financial Officer/Controller services to various start-ups and small corporations from early stage on, as they scale their business, through various exits (public offerings and acquisitions). Ms. Gilmore began her career with Coopers & Lybrand (currently PriceWaterhouseCoopers). She holds a Bachelor of Science degree from California State Polytechnic University, Pomona and is a Certified Public Accountant.

Conyee Lim, M.D.
Conyee Lim, M.D.

Karen Gilmore, CPA

Controller and Administrative Director

Karen Gilmore joined City Hill Ventures in early 2011 as Controller and currently serves as Vice President of Finance at Erasca. She has supported multiple portfolio companies of City Hill, including Erasca, Ignyta, Eclipse Therapeutics, and Medenovo. Ms. Gilmore has more than 25 years of experience serving both public and private companies in multiple industries, with a heavy concentration in biotech and medical device. Ms. Gilmore has provided Chief Financial Officer/Controller services to various start-ups and small corporations from early stage on, as they scale their business, through various exits (public offerings and acquisitions). Ms. Gilmore began her career with Coopers & Lybrand (currently PriceWaterhouseCoopers). She holds a Bachelor of Science degree from California State Polytechnic University, Pomona and is a Certified Public Accountant.

Zachary Hornby

Zachary Hornby

Operating Partner, City Hill Ventures

Zachary “Zach” Hornby has served in both operating and director roles for multiple different City Hill portfolio companies. He is currently the Chief Executive Officer, President and a Director at Boundless Bio. He is also a Director at Aardvark Therapeutics. Prior to joining Boundless Bio, Mr. Hornby was Chief Executive Officer, President and a Director at Optera Therapeutics Corp, a company that was developing multiple clinical-stage cellular therapies that had been innovated at MD Anderson Cancer Center. He previously served as Chief Operating Officer at Ignyta, where he oversaw development of the company’s portfolio of four clinical stage therapeutics and was the team leader for the company’s lead program, entrectinib, the first drug in pharmaceutical history to garner the coveted BTD (FDA), PRIME (EMA) and Sakigake (PMDA) designations. Mr. Hornby served in roles of increasing responsibility across business development, marketing, new product planning, finance and regulatory affairs at Fate Therapeutics, Halozyme Therapeutics, Neurocrine Biosciences and TKT (now the Human Genetic Therapies division within Takeda/Shire), and was a life sciences consultant at L.E.K. Consulting. He holds B.S. and M.S. degrees in biology, with a concentration in neuroscience, from Stanford University and an M.B.A. from Harvard Business School.

Conyee Lim, M.D.

Co-President and Co-Founder, City Hill Foundation

Dr. Conyee Lim serves as President of the City Hill Foundation, which she co-founded with Dr. Jonathan Lim in 2011. She currently serves on the Board of Directors of Hope for San Diego, a non-profit organization that engages its community to care for and invest in its underserved neighbors in the city of San Diego. Prior to City Hill Foundation, Dr. Lim served for more than a decade as a hospitalist physician in internal medicine at Kaiser Permanente in Southern California. Her residency training was in internal medicine at New England Medical Center. She holds a B.A. degree in human biology from Stanford University and an M.D. from McGill University.

Conyee Lim, M.D.
Conyee Lim, M.D.

Conyee Lim, M.D.

Co-President and Co-Founder, City Hill Foundation

Dr. Conyee Lim serves as President of the City Hill Foundation, which she co-founded with Dr. Jonathan Lim in 2011. She currently serves on the Board of Directors of Hope for San Diego, a non-profit organization that engages its community to care for and invest in its underserved neighbors in the city of San Diego. Prior to City Hill Foundation, Dr. Lim served for more than a decade as a hospitalist physician in internal medicine at Kaiser Permanente in Southern California. Her residency training was in internal medicine at New England Medical Center. She holds a B.A. degree in human biology from Stanford University and an M.D. from McGill University.

Zachary Hornby

David Beaubaire

Senior Advisor, City Hill Arts

David Beaubaire has worked in the movie business for more than 20 years and has developed, overseen and contributed to over 50 movies, including major blockbusters and Academy Award nominated films. He has worked directly with some of the biggest movie stars and acclaimed filmmakers of our time. Mr. Beaubaire most recently worked as an Executive Vice President at Sony, both at Columbia Pictures and TriStar, after serving in similar roles at Paramount Pictures and DreamWorks SKG. In these positions, he has an extensive track record initiating and playing a pivotal role in a wide variety of commercially successful and critically-acclaimed films, including All the Money in the World, Baby Driver, Money Monster, The Big Short, Flight, Up in the Air and Jack Ryan. Mr. Beaubaire is also a member of the Academy of Motion Picture Arts and Sciences and on the Board of Directors of the Entertainment Industry Foundation. Previously, he worked at the White House as Special Assistant and Senior Advisor in the Office of Cabinet Affairs for President Clinton. He is a graduate of Emory University.

Jeff Ivers, CPA

COO, City Hill Arts

Jeff Ivers was one of the first employees of Participant Media, the production financing company formed by eBay’s Jeff Skoll in 2004 to wed film, television and web content to campaigns for social action. Hired as CFO, Mr. Ivers became head of business affairs in 2005, then Executive Vice President of Business Affairs and M&A, before ascending to COO in 2009. He has worked on hundreds of films and received executive producing credits on more than 20 films, including An Inconvenient Truth, the Academy Award-winning documentary that spotlighted Al Gore’s crusade against climate change. As COO, Mr. Ivers negotiated Participant’s financial stake in more than 70 films, including Academy Award winner for Best Picture Spotlight, Lincoln, The Help, The Best Exotic Marigold Hotel, and Charlie Wilson’s War, along with investments in other media companies, including Summit Entertainment, Cineflix, the Audience, Evolution Media Partners (with TPG and EMC) and the $250 million Participant/ImageNation Abu Dhabi film fund.

Following an eight year career as a CPA with Arthur Andersen & Co., Mr. Ivers started in Hollywood in 1983 as Corporate Controller of the MGM/UA Home Entertainment Group, later becoming Senior Vice President of MGM/UA Telecommunications. Mr. Ivers later co-founded Triton Pictures, a theatrical distribution company. He joined production company Motion Picture Corporation of America as CFO in 1994, rising to COO before selling the company to Orion in 1997, serving as Orion’s Executive VP of Motion Picture Finance and Administration until its acquisition by MGM/UA. Mr. Ivers holds a B.S. in Economics from the City University of New York, is a N.Y. State CPA and member of the Executive Branch of the Academy of Motion Picture Arts and Sciences. He has consulted for PBS, United Artists, LIVE Entertainment, Cinetel and Alchemy Entertainment.

Conyee Lim, M.D.
Conyee Lim, M.D.

Jeff Ivers, CPA

COO, City Hill Arts

Jeff Ivers was one of the first employees of Participant Media, the production financing company formed by eBay’s Jeff Skoll in 2004 to wed film, television and web content to campaigns for social action. Hired as CFO, Mr. Ivers became head of business affairs in 2005, then Executive Vice President of Business Affairs and M&A, before ascending to COO in 2009. He has worked on hundreds of films and received executive producing credits on more than 20 films, including An Inconvenient Truth, the Academy Award-winning documentary that spotlighted Al Gore’s crusade against climate change. As COO, Mr. Ivers negotiated Participant’s financial stake in more than 70 films, including Academy Award winner for Best Picture Spotlight, Lincoln, The Help, The Best Exotic Marigold Hotel, and Charlie Wilson’s War, along with investments in other media companies, including Summit Entertainment, Cineflix, the Audience, Evolution Media Partners (with TPG and EMC) and the $250 million Participant/ImageNation Abu Dhabi film fund.

Following an eight year career as a CPA with Arthur Andersen & Co., Mr. Ivers started in Hollywood in 1983 as Corporate Controller of the MGM/UA Home Entertainment Group, later becoming Senior Vice President of MGM/UA Telecommunications. Mr. Ivers later co-founded Triton Pictures, a theatrical distribution company. He joined production company Motion Picture Corporation of America as CFO in 1994, rising to COO before selling the company to Orion in 1997, serving as Orion’s Executive VP of Motion Picture Finance and Administration until its acquisition by MGM/UA. Mr. Ivers holds a B.S. in Economics from the City University of New York, is a N.Y. State CPA and member of the Executive Branch of the Academy of Motion Picture Arts and Sciences. He has consulted for PBS, United Artists, LIVE Entertainment, Cinetel and Alchemy Entertainment.

Zachary Hornby

Michael Kolko

Senior VP of Production, City Hill Arts

Michael Kolko has extensive experience in the media and entertainment industry as a seasoned Producer, Director (DGA), 1st and 2nd unit, Unit Production Manager, Production Executive and Production Accountant. His global producing/directing experience includes unit production management, supervising physical production/post personnel and accountants, budgeting, scheduling, monitoring cash flow/funding and completion/ delivery. He was hired by director John Landis on his film Oscar in 1991 to work in the accounting department, followed by similar work on more than one dozen motion pictures for 20th Century Fox, Walt Disney Pictures, Sony Pictures, Warner Brothers, Universal and MGM. Select studio credits include Speed, Nixon, Rising Sun, Beverly Hillbillies, Hoffa, Last Man Standing, Final Analysis, Fair Game, The Cure, When a Man Loves a Woman and Hard Rain. Mr. Kolko created the Production Tax Incentive division at CAPS Payroll, and was instrumental in acquiring over 150 tax incentives worldwide for a prestigious list of clients in film, television and commercial production. He is a graduate of Syracuse University.